Similar articles

Abstract: Objective: Recently, a high frequency of mutations in mitochondrial DNA (mtDNA) has been detected in ovarian cancer. To explore the alterations of proteins in mitochondria in ovarian cancer, a pair of human ovarian carcinoma cell lines (SKOV3/SKOV3.ip1) with different metastatic potentials was examined. Methods: Cancer cells SKOV3.ip1 were derived from the ascitic tumor cells of nude mice bearing a tumor of ovarian cancer cells SKOV3. SKOV3.ip1 exhibited a higher degree of migration potential than its paired cell line SKOV3. The proteins in the mitochondria of these two cells were isolated and separated by 2-D gel electrophoresis. The differently expressed proteins were extracted and identified using matrix assisted laser desorption ionisation/time-of-flight/time-of-flight (MALDI-TOF/TOF), and finally a selected protein candidate was further investigated by immunohistochemistry (IHC) method in nude mice bearing tumor tissues of these two cells. Results: A total of 35 spots with different expressions were identified between the two cells using 2D-polyacrylamide gel electrophoresis (PAGE) approach. Among them, 17 spots were detected only in either SKOV3 or SKOV3.ip1 cells. Eighteen spots expressed different levels, with as much as a three-fold difference between the two cells. Twenty spots were analyzed using MALDI-TOF/TOF, and 11 of them were identified successfully; four were known to be located in mitochondria, including superoxide dismutase 2 (SOD2), fumarate hydratase (FH), mitochondrial ribosomal protein L38 (MRPL38), and mRNA turnover 4 homolog (MRTO4). An increased staining of SOD2 was observed in SKOV3.ip1 over that of SKOV3 in IHC analysis. Conclusions: Our results indicate that the enhanced antioxidation and metabolic potentials of ovarian cancer cells might contribute to their aggressive and metastatic behaviors. The underlying mechanism warrants further study.

[1]Bai, F., Feng, J., Cheng, Y., Shi, J., Yang, R., Cui, H., 2006. Analysis of gene expression patterns of ovarian cancer cell lines with different metastatic potentials. Int. J. Gynecol. Cancer, 16(1):202-209.

[2]Chen, Y., McMillan-Ward, E., Kong, J., Israels, S.J., Gibson, S.B., 2007. Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J. Cell Sci., 120(23):4155-4166.

[3]Connor, K.M., Subbaram, S., Regan, K.J., Nelson, K.K., Mazurkiewicz, J.E., Bartholomew, P.J., Aplin, A.E., Tai, Y.T., Aguirre-Ghiso, J., Flores, S.C., et al., 2005. Mitochondrial H₂O₂ regulates the angiogenic phenotype via PTEN oxidation. J. Biol. Chem., 280(17):16916-16924.

[4]Connor, K.M., Hempel, N., Nelson, K.K., Dabiri, G., Gamarra, A., Belarmino, J., van de Water, L., Mian, B.M., Melendez, J.A., 2007. Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells. Cancer Res., 67(21):10260-10267.

[5]Gottlieb, E., Tomlinson, I.P., 2005. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat. Rev. Cancer, 5(11):857-866.

[6]Heerdt, B.G., Houston, M.A., Augenlicht, L.H., 2005. The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression. Cancer Res., 65(21):9861-9867.

[7]Hempel, N., Ye, H., Abessi, B., Mian, B., Melendez, J.A., 2009. Altered redox status accompanies progression to metastatic human bladder cancer. Free Radic. Biol. Med., 46(1):42-50.

[8]Hitchler, M.J., Wikainapakul, K., Yu, L., Powers, K., Attatippaholkun, W., Domann, F.E., 2006. Epigenetic regulation of manganese superoxide dismutase expression in human breast cancer cells. Epigenetics, 1(4):163-171.

[9]Hu, Y., Rosen, D.G., Zhou, Y., Feng, L., Yang, G., Liu, J., Huang, P., 2005. Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. J. Biol. Chem., 280(47):39485-39492.

[10]Huang, X.H., Wang, Q., Chen, J.S., Fu, X.H., Chen, X.L., Chen, L.Z., Li, W., Bi, J., Zhang, L.J., Fu, Q., et al., 2009. Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol. Res., 39(8):786-794.

[11]Hurt, E.M., Thomas, S.B., Peng, B., Farrar, W.L., 2007. Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines. Br. J. Cancer, 97(8):1116-1123.

[12]Lin, Y.W., Aplan, P.D., 2007. Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets. Leukemia, 21(6):1276-1284.

[13]Naora, H., Montell, D.J., 2005. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat. Rev. Cancer, 5(5):355-366.

[14]Nelson, K.K., Ranganathan, A.C., Mansouri, J., Rodriguez, A.M., Providence, K.M., Rutter, J.L., Pumiglia, K., Bennett, J.A., Melendez, J.A., 2003. Elevated SOD2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin. Cancer Res., 9(1):424-432.

[15]Newmeyer, D.D., Ferguson-Miller, S., 2003. Mitochondria: releasing power for life and unleashing the machineries of death. Cell, 112(4):481-490.

[16]Pani, G., Koch, O.R., Galeotti, T., 2009. The p53-p66shc-manganese superoxide dismutase (MnSOD) network: a mitochondrial intrigue to generate reactive oxygen species. Int. J. Biochem. Cell Biol., 41(5):1002-1005.

[17]Salzman, R., Kankova, K., Pacal, L., Tomandl, J., Horakova, Z., Kostrica, R., 2007. Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases. Neoplasma, 54(4):321-325.

[18]Stewart, L., Glenn, G.M., Stratton, P., Goldstein, A.M., Merino, M.J., Tucker, M.A., Linehan, W.M., Toro, J.R., 2008. Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. Arch. Dermatol., 144(12):1584-1592.

[19]Sudarshan, S., Sourbier, C., Kong, H.S., Block, K., Valera Romero, V.A., Yang, Y., Galindo, C., Mollapour, M., Scroggins, B., Goode, N., et al., 2009. Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1α stabilization by glucose-dependent generation of reactive oxygen species. Mol. Cell. Biol., 29(15):4080-4090.

[20]Takada, S., Inoue, E., Tano, K., Yoshii, H., Abe, T., Yoshimura, A., Akita, M., Tada, S., Watanabe, M., Seki, M., et al., 2009. Generation and characterization of cells that can be conditionally depleted of mitochondrial SOD2. Biochem. Biophys. Res. Commun., 379(2):233-238.

[21]Wang, Y., Liu, V.W., Xue, W.C., Cheung, A.N., Ngan, H.Y., 2006. Association of decreased mitochondrial DNA content with ovarian cancer progression. Br. J. Cancer, 95(8):1087-1091.

[22]Xu, Y., Fang, F., Dhar, S.K., Bosch, A., St. Clair, W.H., Kasarskis, E.J., St. Clair, D.K., 2008. Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells. Mol. Cancer Res., 6(12):1881-1893.

[23]Ye, H., Wang, A., Lee, B.S., Yu, T., Sheng, S., Peng, T., Hu, S., Crowe, D.L., Zhou, X., 2008. Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma. Cancer Genomics Proteomics, 5(2):85-94.

[24]Yogev, O., Yogev, O., Singer, E., Shaulian, E., Goldberg, M., Fox, T.D., Pines, O., 2010. Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol., 8(3):e1000328.

[25]Zejnilovic, J., Akev, N., Yilmaz, H., Isbir, T., 2009. Association between manganese superoxide dismutase polymorphism and risk of lung cancer. Cancer Genet. Cytogenet., 189(1):1-4.